PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56
Cancer 1,053,491 Disease Target Adp/Atp Translocase 3 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Alli (Orlistat 60 mg)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Azelaic Acid Cream (Azelex)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Dragonamide E 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Azelex (Azelaic Acid Cream)- FDA 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Disease Sever Condition 2 1 0.00 -0.71 0.50 0.56
Cancer 1,053,491 Disease Drug Aranesp (Darbepoetin Alfa)- FDA 20 6 0.00 -0.84 0.30 0.56
Cancer 1,053,491 Disease Target Steroid 5-Alpha-Reductase 293 49 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Disease Myelodysplastic Syndrome 7,378 603 0.01 -0.96 0.08 0.56
Cancer 1,053,491 Disease Target Collapsin Response Mediator Protein-1 30 8 0.00 -0.86 0.27 0.56
Cancer 1,053,491 Disease Target beta-Cellulin 17 5 0.00 -0.84 0.29 0.56
Cancer 1,053,491 Disease Target Glutathione Peroxidase 3 132 25 0.00 -0.90 0.19 0.56
Cancer 1,053,491 Disease Target Endothelin A Receptor 722 94 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Target BMX 185 32 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Drug Alemtuzumab (Campath)- FDA 32 8 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Target CCL2 3,560 327 0.01 -0.95 0.09 0.56
Cancer 1,053,491 Disease Target ACVR1B 23 6 0.00 -0.86 0.26 0.56
Cancer 1,053,491 Disease Disease Inflammatory Bowel Diseases 4,684 400 0.01 -0.96 0.09 0.56
Cancer 1,053,491 Disease Disease Hepatitis B 57,815 2,912 0.01 -0.97 0.05 0.56
Cancer 1,053,491 Disease Target CCL18 256 40 0.00 -0.92 0.16 0.56
Cancer 1,053,491 Disease Target CXCL3 145 25 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Drug Drometrizole 10 3 0.00 -0.84 0.30 0.56
Cancer 1,053,491 Disease Target DNA-damage-inducible transcript 3 30 7 0.00 -0.88 0.23 0.56
Cancer 1,053,491 Disease Disease Secondhand Smoke 1,334 142 0.00 -0.95 0.11 0.56
Cancer 1,053,491 Disease Disease Malnutrition 27,452 1,566 0.01 -0.97 0.06 0.56
Cancer 1,053,491 Disease Target Glutathione S-Transferase A3 15 4 0.00 -0.86 0.27 0.56
Cancer 1,053,491 Disease Disease Infertility 35,448 1,911 0.01 -0.97 0.05 0.56
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Disease Thromboembolic Disease 3,336 290 0.00 -0.96 0.09 0.56
Cancer 1,053,491 Disease Disease Liver Disease 49,817 2,478 0.01 -0.97 0.05 0.56
Cancer 1,053,491 Disease Disease Andropause 317 44 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target Glutathione S-Transferase A1 111 19 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Drug Kaempferol 2,992 258 0.00 -0.96 0.09 0.56
Cancer 1,053,491 Disease Target Peroxisome Proliferator-Activated Receptor Delta 355 47 0.00 -0.93 0.13 0.56
Cancer 1,053,491 Disease Target DAPK2 27 6 0.00 -0.88 0.22 0.56
Cancer 1,053,491 Disease Target CCL5 2,002 186 0.00 -0.95 0.09 0.56
Cancer 1,053,491 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target CXCL14/BRAK 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Drug Amaryl (Glimepiride)- FDA 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target ENO2 87 15 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Disease Ovarian Cyst 1,959 178 0.00 -0.95 0.09 0.56
Cancer 1,053,491 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 3 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Disease Pneumonia 81,521 3,526 0.01 -0.98 0.04 0.56
Cancer 1,053,491 Disease Target CD146 729 79 0.00 -0.94 0.11 0.55
Cancer 1,053,491 Disease Target EG-VEGF 63 11 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target Dihydrofolate Reductase 5,563 401 0.01 -0.96 0.07 0.55
Cancer 1,053,491 Disease Target Collagenase 3 367 45 0.00 -0.94 0.12 0.55
Cancer 1,053,491 Disease Target EPHB1 137 20 0.00 -0.92 0.15 0.55